{
    "clinical_study": {
        "@rank": "9797", 
        "arm_group": {
            "arm_group_label": "Severe Asthma", 
            "description": "Patients with severe asthma as specified under inclusion, exclusion criteria"
        }, 
        "brief_summary": {
            "textblock": "Asthma is a chronic illness characterized by inflammation of the airways. Severe asthma is\n      defined in the literature as asthma not controlled by medication. In recent years it has\n      become known that severe asthma is a variable disease and has subtypes relating to the age\n      of onset, type of inflammation and allergy, obesity, etc.\n\n      Our aim is to characterize the phenotypes of severe asthma population in our clinic and\n      compare the prevalent phenotypes to the phenotypes described before."
        }, 
        "brief_title": "The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Study measures will include the following:\n\n        -  asthma demographic and symptoms questionnaire\n\n        -  Validation of proper inhaler technique\n\n        -  Height, weight measurements\n\n        -  Forced spirometry and reversibility testing\n\n        -  DLCO\n\n        -  Fractional  excretion of NO in exhaled breath\n\n        -  Chest and sinus CT\n\n        -  Induced sputum analysis\n\n        -  Complete blood count, electrolytes, immunoglobulin E, Aspergillus Specific IgE\n\n        -  Skin allergy testing"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Presence of Asthma- typical symptoms and signs accompanied by either: a. obstruction\n             in  Spirometry, OR- b. positive methacholine test\n\n          2. Regular use of high dose of inhaled corticosteroids (1000 micrograms of fluticasone\n             per day or equivalent) in addition to a long acting beta agonist (LABA).\n\n          3. Lack of asthma control- 2 or more exacerbations in the past year- exacerbations\n             defined by hospitalization or care in an emergency department or treatment with\n             systemic glucocorticosteroids for exacerbation of asthma symptoms.\n\n        Exclusion Criteria:\n\n          1. Presence of another relevant respiratory illness, such as chronic obstructive\n             pulmonary disease (COPD)\n\n          2. lack of adherence to medical therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Population of petients with severe asthma, described by presence of symptoms despite\n        adequate treatment as described in the following sections."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01741805", 
            "org_study_id": "CMC-12-0032-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "Severe Asthma", 
            "description": "Demographic data, Spirometry, induced sputum, IgE, Aspergillus specific IgE", 
            "intervention_name": "Severe Asthma", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 23, 2012", 
        "location": {
            "contact": {
                "last_name": "Pashkov", 
                "phone": "972-4-8250517"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "34632"
                }, 
                "name": "Pulmonology Institute, Carmel Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Elena Pashkov, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Michal Shteinberg, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa.", 
        "overall_contact": {
            "email": "elenapa@clalit.org.il", 
            "last_name": "Elena Pashkov, MD", 
            "phone": "972-4-8250517"
        }, 
        "overall_contact_backup": {
            "email": "michal.shteinberg@gmail.com", 
            "last_name": "Michal Shteinberg, MD, PhD", 
            "phone": "972-4-8250517"
        }, 
        "overall_official": {
            "affiliation": "Pulmonology Institute, Carmel Medical Center", 
            "last_name": "Michal Shteinberg, MD,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Forced Expiratory Volume in 1 second (FEV1)", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01741805"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Carbon Monoxide Diffusion Capacity (DLCO)", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Percent eosinophils in induced sputum sample", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Bronchiectasis on computerized tomography (CT)", 
                "safety_issue": "No", 
                "time_frame": "1 year)"
            }, 
            {
                "measure": "Blood level of Total immunoglobulin E (IgE)", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Presence of blood antibody to Aspergillus Fumigatus", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Fraction of Nitric Oxide (NO) in expired air", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Carmel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Carmel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}